The United States Patent and Trademark Office has issued the notice of allowance for its U.S. Patent Application entitled "Transdermal Therapeutic System Containing Asenapine“.

LTS Lohmann Therapie-Systeme AG has entered into a research collaboration agreement for the evaluation of LTS Micro Array Patch (MAP) technology.

Dr. Sebastian Braun will present “Dissolvable microarray systems - An industry view regarding development and manufacturing of a new dosage form”.

Microneedle systems - is easier to ship, easier to use and painless for the patient. Join this free web seminar to understand the advantages of microneedle systems.

The "Highest Reputation" award for LTS. The study assessed the reputation for Management, Sustainability, Products and Services, Performance as Employer, and Business Performance.